Omega Healthcare Investors Inc.

Day range

$45.89 – $46.85

Open

$46.49

Prev close

$46.30

Volume

1.86M

Market cap

$14.03B

Shares out

303.01M

P/E

16.67

P/S

11.87

P/B

2.60

P/FCF

30.80

ROE

15.6%

ROA

8.4%

Debt/Equity

0.75

Div yield

5.67%

As of Oct 22, 2026

• Executive leadershipOct 1, 2026

  “effective October 1, 2026, the Board ... appointed Matthew P. Gourmand, the Company's President, to serve as the Company's President and Chief Executive Officer.”

• Shareholder meetingsJun 5, 2026

  On June 5, 2026, Omega Healthcare Investors, Inc. ("Omega" or the "Company") held its 2026 Annual Meeting of Stockholders (the "Annual Meeting"). At the Annual Meeting, the holders of 255,926,290 shares of Omega's common stock were present in person or represented by proxy, representing approximately 85.93% of the total outstanding common stock as of the record date for the Annual Meeting. Each of the director nominees was elected, the selection of Ernst & Young LLP was ratified and Omega's executive compensation was approved on an advisory basis.

• Executive leadershipMay 21, 2026

  Lucas M. Golem, the Company's Vice President of Financial Reporting, to succeed Mr. Ballew's position and serve as the Company's Chief Accounting Officer, both effective as of the CFO Transition Date.

• Executive leadershipJan 7, 2026

  As of January 1, 2026, Omega Healthcare Investors, Inc. (the "Company") entered into amendments of the employment agreements of each of the Company's named executive officers to extend the term of their respective employment agreements by one year to December 31, 2028, and revise their annual salaries in accordance with the annual review conducted by the Compensation Committee of the Board of Directors.

• Equity activityNov 3, 2025

  On November 3, 2025, Omega Healthcare Investors, Inc. (the "Company") entered into an "at-the-market" equity offering sales agreement (the "Sales Agreement") with each of the institutions named therein relating to (i) the issuance and sale by the Company to or through the Sales Agents, from time to time, of shares (the "Issuance Shares") of the Company's common stock, par value $0.10 per share ("Common Stock"), and (ii) the sale by the Forward Sellers, as agents on behalf of the Forward Purchasers, of Common Stock (the "Forward Shares" and, together with the Issuance Shares, the "Securities"), with the Securities to be sold under the Sales Agreement not to exceed an aggregate gross sales price of $2,000,000,000.

• SBRASabra Healthcare REIT, Inc.-0.20%
• CTRECareTrust REIT, Inc+0.00%
• LTCLTC Properties, Inc.+0.97%
• NHINational Health Investors+0.15%
• VTRVentas, Inc.-0.22%

Days to cover

7.8

Short interest

15.81M

Avg volume

2.03M

As of Sep 30, 2026 · reported to FINRA twice monthly.

• Aging Population Boosts Healthcare REITs: Stocks to Watch
  positiveZacks Investment Research· Oct 21, 2026
• PINE or OHI: Which Is the Better Value Stock Right Now?
  positiveZacks Investment Research· Oct 14, 2026
• DRH or OHI: Which Is the Better Value Stock Right Now?
  positiveZacks Investment Research· Sep 23, 2026
• PACS Expands Florida Footprint With 32-Facility Acquisition
  positiveZacks Investment Research· Sep 8, 2026
• GLPI vs. OHI: Which Stock Is the Better Value Option?
  positiveZacks Investment Research· Aug 27, 2026